Back to Search
WILLIAM KELLY, MD
MD
Medical Oncology Physician
NPI: 1720422421IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
S7897(TX)
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
MD043981(DC)BP10047120(TX)
Education
OTHER
Class of 2013
Clinical Trials (1)
1
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
Efficacy of carboplatin-taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials.
PMID 19633053·Ann Oncol·2010
8-other
TROG 96.01: TTBF and PSAdt as surrogates for disease specific mortality.
PMID 19655026·Update Cancer Ther·2009
8-other
Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer.
PMID 19375217·Eur Urol·2009
3-trial
Revised delta34S reference values for IAEA sulfur isotope reference materials S-2 and S-3.
PMID 19288548·Rapid Commun Mass Spectrom·2009
8-other
Analysis of the indanomycin biosynthetic gene cluster from Streptomyces antibioticus NRRL 8167.
PMID 19301315·Chembiochem·2009
8-other
A C. elegans LSD1 demethylase contributes to germline immortality by reprogramming epigenetic memory.
PMID 19379696·Cell·2009
7-preclinical
Thiostrepton biosynthesis: prototype for a new family of bacteriocins.
PMID 19265401·J Am Chem Soc·2009
8-other
The wisdom of Weismann: epigenetic erasure mechanisms and germ line immortality.
PMID 19556871·Cell Cycle·2009
8-other
Epothilones: tubulin polymerization as a novel target for prostate cancer therapy.
PMID 19048010·Nat Clin Pract Oncol·2009
6-review
An open-label, multicenter, phase I/II study of single-agent AT-101 in men with castrate-resistant prostate cancer.
PMID 19366825·Clin Cancer Res·2009
3-trial
Clinical and polysomnographic predictors of short-term continuous positive airway pressure compliance.
PMID 19017888·Chest·2009
8-other
Diabetes Medication Satisfaction Tool: a focus on treatment regimens.
PMID 18931098·Diabetes Care·2009
8-other
Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer.
PMID 19364960·J Clin Oncol·2009
3-trial
Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer: results of Cancer and Leukemia Group B 99811.
PMID 18989865·Cancer·2008
3-trial
A phase II study of estramustine, docetaxel, and exisulind in patients with hormone- refractory prostate cancer: results of cancer and leukemia group B trial 90004.
PMID 18824434·Clin Genitourin Cancer·2008
3-trial
The genomic distribution and function of histone variant HTZ-1 during C. elegans embryogenesis.
PMID 18787694·PLoS Genet·2008
7-preclinical
Intramolecular cyclizations of polyketide biosynthesis: mining for a "Diels-Alderase"?
PMID 19039353·Org Biomol Chem·2008
6-review
Reclassification of Clostridium proteoclasticum as Butyrivibrio proteoclasticus comb. nov., a butyrate-producing ruminal bacterium.
PMID 18768601·Int J Syst Evol Microbiol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 30 Convent Dr
Bethesda, MD 20892 - Phone
- (301) 402-2592
Quick Facts
- NPI
- 1720422421
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 13
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile